Cholesterolosis is not associated with high cholesterol levels in patients with and without gallstone disease

Journal of Clinical Gastroenterology

Volumn 25, Issue 3, 1997, Pages 518-521

  Méndez Sánchez, Nahum ^a   Tanimoto, Miguel A ^a   Cobos, Ernesto ^a   Roldán Valadez, Ernesto ^a   Uribe, Misael ^a,b  

^a LIVER RESEARCH UNIT   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Cholelithiasis; Cholesterol; Cholesterolosis; Obesity

Indexed keywords

ADULT; AGED; ARTICLE; CHOLESTEROL BILE LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GALLSTONE; GALLSTONE FORMATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; BODY MASS INDEX; CHOLELITHIASIS; CHOLESTEROL; FEMALE; GALLBLADDER; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; OBESITY;

EID: 0030660453     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199710000-00007     Document Type: Article

References (30)

1. Holzbach RT. Effects of gallbladder function on human bile: compositional and structural changes. Hepatology 1984;4:57S-60S.
2. LaMont JT, Carey MC. Cholesterol gallstone formation. 2. Pathobiology and pathomechanics. Prog Liver Dis 1992;10:165-91.
3. Behar J, Lee KY, Thompson WR, Biancani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989;97:1479-84.
4. Sahlin S, Stahlberg D, Einarsson K. Cholesterol metabolism in liver and gallbladder mucosa of patients with cholesterolosis. Hepatology 1995;21:1269-75.
5. GREPCO: The epidemiology of gallstone disease in Rome, Italy. Part I. Prevalence data in men. Part II. The epidemiology of gallstone disease in Rome, Italy. Hepatology 1988;8:904-13.
6. Jorgensen T. Gallstone in a Danish population. Relation to weight, physical activity, smoking, coffee consumption and diabetes mellitus. Gut 1989;30:528-34.
7. Diehl AK, Haffner SM, Knapp JA, et al. Dietary intake and the prevalence of gallbladder disease in Mexican Americans. Gastroenterology 1989;97:1527-33.
8. Carey MC. Pathogenesis of gallstones. Am J Surg 1993;165:410-9.
9. González-Villalpando C, Stern MP. La obesidad es un factor de riesgo cardiovascular con gran prevalencia en México. Estudio en población abierta. Rev Invest Clin (Méx) 1993;45:13-19.
10. Mittinen TA. Cholesterol production in obesity. Circulation 1971; 44:842-50.
11. Thornton JR, Heaton KW, MacFarlane GG. A relation between high density-lipoproteins, cholesterol, and bile cholesterol saturation. BMJ 1981;283:1352-4.
12. The Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. Hepatology 1988;8:907-13.
13. Jorgensen T. Gallstones and plasma lipids a Danish population. Scand J Gastroenterol 1989;24:916-22.
14. Kono S, Kochi S, Ohyyama S, Wakisaka A. Gallstones, serum lipids and glucose tolerance among male officials of Self-Defense Forces in Japan. Dig Dis Sci 1988;7:839-44.
15. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones. A case control study. Gastroenterology 1990;99:843-49.
16. Angelico M. Serum lipid and gallstone disease. In: Capocaccia L, et al. eds. Recent Advances in the Epidemiology and Prevention of Gallstones Disease. Amsterdam: Kluwer, 1991:121-7.
17. Halpern Z, Rubin M, Harach G, et al. Bile and plasma lipid composition in non-obese normo-lipidemic subjects with and without cholesterol gallstones. Liver 1993;13:246-52.
18. Méndez-Sánchez N, Ponciano-Rodríguez G, Cárdenas-Vazquez R, Uribe M. Pathophysiology of cholesterol gallstone disease. Arch Med Res 1996;27:433-41.
19. Smith JL, Hardie IR, Pillay SP, de Jersey J. Hepatic acyl-coenzyme A: cholesterol acyltransferase activity is decreased in patients with cholesterol gallstones. J Lipid Res 1990;31:1993-2000.
20. Reihnér E, Angelin B, Björkhem Y, Einarsson K. Hepatic cholesterol metabolism in cholesterol gallstone disease. J Lipid Res 1991;32:469-75.
21. Sahlin S, Ahlberg J, Reihnér E, Stahlberg D, Einarsson K. Cholesterol metabolism in human gallbladder mucosa: relationship to cholesterol gallstone disease and effects of chenodexoycholic acid and ursodeoxycholic acid treatment. Hepatology 1992;16: 320-6.
22. Salen G, Nicolau G, Shefer S, Mosbach EH. Hepatic cholesterol metabolism in patients with gallstones. Gastroenterology 1975;69:676-84.
23. Carey MC, Hernell O. Fat digestion and absorption. Semin Gastrointest Dis 1992;3:189-208.
24. LaMont JT, Carey MC. Cholesterol gallstone formation 2. Pathobiology and pathomechanics. Prog Liver Dis 1992;10:165-91.
25. Koga A, Tondon S, Nishimura M. Electron microscopic observations on cholesterolosis of the gallbladder, with special reference to its pathogenesis. Nihon Shokakibyo Gakkai Zasshi. Jpn J Gastroenterol 1974;71:1085-1101.
26. Feldman M, Feldman M Jr. Cholesterolosis of the gallbladder. An autopsy study of 165 cases. Gastroenterology 1954;27:641-8.
27. Izeki J, Ushiyama K, Beppu T, et al. Polyp of the gallbladder: a clinical and pathological study. Nihon Geka Gakkai Zasshi. J Jpn Surg Soc 1982;83:1429-36.
28. Celoria GC, Rodríguez-Otero JC, Proske SA, Vallilongua C. Papillary hyperplasta and cholesterolosis of the gallbladder. Med Buenos Aires 1994;54:31-4.
29. Van der Werf SDJ, Van Berge Henegouwen GP, Palsma DMH, Ruben ATH. Motor function of the gallbladder and cholesterol saturation of duodenal bile. Neth J Med 1987;30:160-71.
30. Salmemkivi K. Cholesterolosis of gallbladder. Acta Chir Scand 1964;128:(Suppl 324):1-93.